EBITDA Margins improved by 239bps QoQ largely supported by lower G&A; expenses (down 120bps QoQ). Better business mix, improvement in utilisation, higher IP deals & higher onsite utilisation would drive PSYS' profit margins going forward. Revenue and PAT are expected to grow at 14% and 20% CAGR over FY1820E. While EBITDA Margins are expected to improve from 15.5% in FY18 to...